H]SQ29548 to thromboxane A 2 receptor in intact platelets in a concentration-dependent manner. These results suggest that Piper longum L. contains a constituent(s) that inhibits platelet aggregation as a non-competitive thromboxane A 2 receptor antagonist.
Injury to the blood vessel wall triggers rapid platelet activation and platelet plug formation, followed by the occurrence of blood coagulation and the formation of fibrin-containing thrombi that occlude the site of injury. These events limit vital blood loss at the site of injured tissue, but may also block narrow or diseased vessels, leading to ischemia and/or tearing in vital organs. 1, 2) In addition, platelet aggregation and subsequent thrombus formation in coronary and cerebral arteries may cause myocardial infarction and stroke, respectively.
3) Platelets play important roles in thrombus formation in injured blood vessels. Platelet aggregation is regulated by several physiological agonists such as 5-hydroxytryptamine (5-HT), epinephrine, adenosine 5Ј-diphosphate (ADP), and thromboxane A 2 (TXA 2 ). 2) TXA 2 is a metabolite of arachidonic acid with a chemical half-life of about 30 s. When TXA 2 is released from activated platelets, it binds to TXA 2 receptors and causes platelet shape change and aggregation 4) as a positive feedback mediator. TXA 2 receptor, one of the G protein-coupled receptors, interacts with heterotrimeric G proteins G q/11 , G i/o , and G 12/13 . [5] [6] [7] [8] It is known that stimulation of the TXA 2 receptor results in platelet shape change mainly through the G 12/13 pathway 9) and subsequent aggregation through the G q/11 pathway. 10, 11) The activation of phospholipase C-b (PLC-b) via G q/11 produces inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG), as second messengers, through hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP 2 ). 12) IP 3 increases intracellular Ca 2ϩ concentration by releasing Ca 2ϩ from Ca 2ϩ storage sites and DAG activates protein kinase C (PKC). 10) TXA 2 -induced platelet aggregation is important for thrombus formation in vascular beds, and because of this nonsteroidal anti-inflammatory drugs (NSAIDs) and TXA 2 synthase inhibitor such as aspirin, indomethacin, and ozagrel are clinically used for reducing TXA 2 -mediated platelet aggregation by decreasing TXA 2 synthesis in platelets. 13, 14) Piper longum L., which has been used as a spice, contains various constituents such as piperine, piperlongumine, and b-(3,4,5-trimethoxyphenyl)propionic acid (TMPPA). Piper longum L. has also been used as a crude drug to improve intestinal disorder, asthma, and poor peripheral blood circulation in Asia. In particular, its efficacy against the latter indication is well known in the region. 15) Although it is generally believed that platelet function affects the poor peripheral blood circulation through platelet aggregation and thrombosis formation, the pharmacological effect of Piper longum L. on platelets function remains to be solved. In the present study, we examined the effects of several extracts of Piper longum L. on rabbit platelet aggregation, and show that the ethanol extract of Piper longum L. inhibits platelet aggregation through antagonizing the TXA 2 receptor. Piper longum L. has been used as a crude drug for the treatment of disorders of poor peripheral blood circulation in Asia. However, the detailed mechanism of its action has not been clarified as yet. In the present study, we examined the effects of several extracts of Piper longum L. on rabbit platelet function. Thromboxane A 2 receptor agonist U46619 caused rabbit platelet aggregation, which was potently inhibited by the ethanol or butanol extract of Piper longum L. The ethanol extract inhibited U46619-induced platelet aggregation in a concentration-dependent manner, but only weakly inhibited that induced by thrombin. The maximum response to U46619 was reduced by 100% ethanol extract concentration dependently, suggesting that the inhibitory mode of U46619-induced platelet aggregation by the ethanol extract was non-competitive. The extract also inhibited U46619-induced phosphoinositide hydrolysis with a similar concentration dependency to the platelet aggregation. Furthermore, the extract inhibited binding of [ F), or 2 l of 100% butanol (extract-G), and the extract was evaporated under reduced pressure followed by lyophilization. The obtained extracts were 20.8 g for extract-A, 19.8 g for extract-B, 28.1 g for extract-C, 19.0 g for extract-D, 17.5 g for extract-E, 14.4 g for extract-F, and 13.9 g for extract-G. The extracts were dissolved in 100% dimethylsulfoxide (DMSO) to make a concentration of 100 mg/ml, and were used with a concentration of DMSO <1%.
MATERIALS AND METHODS

Materials
Determination of Components in Piper longum L. Extracts For the determination of piperine, Piper longum L. extracts were dissolved in 99% ethanol and analyzed by reversed-phase HPLC (Column ODS, Wakosil-II5c-18HG, 4.6ϫ250 mm at 40°C, UV determined at 345 nm). The flow rate was 1.0 ml/min, and the solvents used for separation were mixtures of acetonitrile/tetrahydrofuran/water : 160/40/ 345 (v/v). For the determination of piperlongumine and TMPPA, Piper longum L. extracts were dissolved in 50% methanol and analyzed by reversed-phase HPLC (by the same method as for piperine, but UV determined at 280 nm). The flow rate was 1.0 ml/min, and the solvents used for separation were mixtures of 0.1% trifluoroacetic acid (TFA) and 0.1% TFA/methanol, increasing 0.1% TFA/methanol (50-95% linear gradient).
Preparation of Washed Platelets Fresh blood was obtained from male rabbits (Japanese white rabbits weighing about 2.5-3.5 kg), collected into plastic tubes containing acid citrate dextrose solution (1/6 volume of blood), composed of citric acid (65 mM), trisodium citrate (85 mM), and dextrose (2%). Then, the blood was centrifuged at 250ϫg for 12 min to obtain platelet-rich plasma. The platelet-rich plasma was centrifuged at 90ϫg to remove contaminated erythrocytes and leukocytes then centrifuged at 450ϫg for 15 min at room temperature (20-25°C). The pellet was washed twice with Tyrode/HEPES solution (NaCl 138.3 mM, KCl 2.68 mM, MgCl 2 · 6H 2 O 1.0 mM, NaHCO 3 4.0 mM, HEPES 10 mM, glucose 0.1%, and bovine serum albumin 0.35% at pH 6.35). The resultant pellet was suspended in the second Tyrode/HEPES solution (pH 7.35) with a final density of 3-5ϫ10 8 platelets/ml. 4) All experimental procedures were performed in accordance with the guidelines of the Animal Experimentation Committee of Tohoku University Graduate School of Pharmaceutical Sciences.
Determination of Platelet Aggregation Platelet aggregation was determined by a standard turbidometric method using an aggregometer (PAM-6C, Merbanix, Tokyo, Japan). 4) Platelet aggregation was expressed as an increase in light transmission. The levels of light transmission were calibrated as 0% for a platelet suspension and 100% for the Tyrode/ HEPES solution (pH 7.35). Platelet suspension (3ϫ10 8 platelets/ml, 0.3 ml) in a cuvette was preincubated at 37°C for 3 min under continuous stirring at 1000 rpm then CaCl 2 was added at a final concentration of 1 mM for 3 min. After the preincubation of the Piper longum L. extract for 5 min, platelet aggregation was monitored for 10 min after the addition of U46619 or thrombin.
Measurement of Inositol Phosphates Washed platelets in albumin-free Tyrode/HEPES solution (pH 7.35) were labeled with 25 mCi/ml [ 3 H]inositol at 37°C for 1 h. Then, platelets were washed with albumin-containing Tyrode/ HEPES solution (pH 7.35), and suspended at 3ϫ10 8 platelets/ ml. After preincubation for 10 min, platelets were treated with indicated concentrations of the Piper longum L. extract in the presence of LiCl (10 mM) for 5 min. Then, platelets were stimulated with U46619 for 15 min. The reactions were terminated by addition of an equal volume of ice-cold 10% trichloroacetic acid (TCA). The TCA extracts were washed three times with diethyl ether to remove TCA, and the diethyl ether was removed by keeping the samples at 47°C for 30 min. [ 3 H]Inositol phosphates were separated by anion exchange column (Bio-Rad AG 1X-8, 100-200 mesh, formate form), as previously described. 16 ) Radioactivity of the elute was counted by liquid scintillation spectrophotometer (Beckman, LS 6000 IC, Fullerton, CA, U.S.A.).
Receptor
17)
Data Analysis Data are expressed as meansϮS.E.M. Significant differences were determined by Tukey's-Kramer test or Scheffe test.
RESULTS
Effects of Piper longum L. Extracts on U46619-Induced
Platelet Aggregation First, we examined the effects of several extracts of Piper longum L. on U46619-induced platelet aggregation (Fig. 1) . As the results, hot water extract without crushed Piper longum L. (extract-A), cold water extract with crushed Piper longum L. (extract-B), and hot water extract (extract-C) at a concentration of 100 mg/ml slightly inhibited U46619 (3 mM)-induced platelet aggregation. On the other hand, 30% ethanol extract (extract-D) and 70% ethanol extract (extract-E) at a concentration of 100 mg/ml partially inhibited U46619-induced platelet aggregation. Moreover, 100% ethanol extract (extract-F) and 100% butanol extract (extract-G) at a concentration of 100 mg/ml strongly inhibited U46619-induced platelet aggregation.
Piperine, Piperlongumine, and TMPPA Contents in Piper longum L. Extracts The above extracts of Piper longum L. contained piperine, piperlongumine, and TMPPA at different levels ( Table 1) . Contents of piperine and piperlongumine were high in relatively hydrophobic extract solutions. On the other hand, the content of TMPPA was similar in the extract solutions employed in the present study. The major constituent in 70% ethanol extract, 100% ethanol extract, and 100% butanol extract was piperine, and that in hot water extract without crushing, cold water extract, hot water extract, and 30% ethanol extract was TMPPA. Since 100% ethanol extract and 100% butanol extract had potent inhibitory activity on U46619-induced platelet aggregation, 100% ethanol extract was selected and used further to analyze the detailed mechanism.
Effect of 100% Ethanol Extract on U46619-or Thrombin-Induced Platelet Aggregation To examine the detailed mechanism of inhibitory activity, we compared the effect of 100% ethanol extract on U46619-and thrombin-induced platelet aggregations ( Fig. 2A) . Although the extract (200 mg/ml) inhibited U46619 (3 mM)-induced platelet aggregation, it did not inhibit that induced by thrombin (0.05 U/ ml). Figure 2B shows the concentration-response curves for the 100% ethanol extract in inhibition of U46619-induced platelet aggregation. The extract inhibited U46619-induced platelet aggregation in a concentration-dependent manner with an IC 50 value of about 70 mg/ml. On the other hand, the extract only slightly inhibited thrombin-induced platelet aggregation (Fig. 2B) . In addition, the extract also slightly inhibited ADP-and 5-HT-induced platelet aggregation (data not shown), suggesting that the 100% ethanol extract selectively inhibited U46619-induced platelet aggregation.
Inhibitory Mode of U46619-Induced Platelet Aggregation by 100% Ethanol Extract Because the 100% ethanol extract inhibited U46619-induced platelet aggregation, we examined the inhibitory mode of U46619-induced platelet aggregation by the 100% ethanol extract. U46619 caused platelet aggregation in a concentration-dependent manner, and the maximum response to U46619 was reduced by the 100% ethanol extract in a concentration-dependent manner from 50 to 200 mg/ml (Fig. 3) . Therefore the inhibitory mode of U46619-induced platelet aggregation by the 100% ethanol extract was considered non-competitive.
Effect of 100% Ethanol Extract on U46619-Induced
Phosphoinositide Hydrolysis It is known that stimulation of the TXA 2 receptor causes activation of PLC-b through G q/11 , resulting in phosphoinositide hydrolysis. 12) Because the 100% ethanol extract selectively inhibited U46619-induced platelet aggregation, we examined the effect of the 100% ethanol extract on U46619-induced phosphoinositide hydrol- 
Extract-A, hot water extract without crushing of Piper longum L.; extract-B, cold water extract; extract-C, hot water extract; extract-D, 30% ethanol extract; extract-E, 70% ethanol extract; extract-F, 100% ethanol extract; extract-G, 100% butanol extract. ysis (Fig. 4A) . Although 100% ethanol extract alone did not affect phosphoinositide hydrolysis, it inhibited U46619 (3 mM)-induced phosphoinositide hydrolysis in a concentration-dependent manner with an IC 50 value of about 64 mg/ml.
Effect of 100% Ethanol Extract on [
3 H]SQ29548 Binding to Thromboxane A 2 Receptor Since the 100% ethanol extract inhibited U46619-induced platelet aggregation and phosphoinositide hydrolysis, its site of action was assumed upstream of PLC-b. Therefore we examined the effect of the 100% ethanol extract on binding of TXA 2 receptor antagonist [ 3 H]SQ29548 to TXA 2 receptor (Fig. 4B) . The 100% ethanol extract inhibited [ 
DISCUSSION
Piper longum L., which contains various constituents such as piperine, piperlongumine, and TMPPA, has been used as a crude drug for the treatment of disorders of poor peripheral blood circulation. 15) This disorder is characterized by a reduction of blood flow in peripheral arteries. It is thought that the poor circulation is due to a constriction of peripheral blood vessels and thrombus formation through platelet aggregation. Therefore chemical substances inhibiting the constriction of blood vessels and platelet aggregation could be used for the treatment of poor peripheral blood circulation. 3) In the present study, we demonstrated that 100% ethanol extract (extract-F) and 100% butanol extract (extract-G) of Piper longum L. potently inhibited rabbit platelet aggregation in response to TXA 2 receptor agonist U46619 in vitro (Fig. 1) . The 100% ethanol extract inhibited U46619-induced platelet aggregation in a concentration-dependent manner, while it only weakly inhibited thrombin-induced platelet aggregation (Fig. 2) . Since the 100% ethanol extract also weakly inhibited ADP-and 5-HT-induced platelet aggregation, it seems that the extract selectively inhibits TXA 2 receptor-mediated platelet aggregation. It is known that U46619 causes platelet aggregation mediated mainly through TXA 2 receptor followed by G q/11 , 10, 11) which activates PLC-b, resulting in the production of IP 3 and DAG as second messengers from PIP 2 .
12) Figure 4 shows that the 100% ethanol extract inhibited U46619-induced phosphoinositide hydrolysis and [
3 H]SQ29548 binding to TXA 2 receptor in a concentration-dependent manner. We obtained similar IC 50 values of the 100% ethanol extract of Piper longum L. to the TXA 2 receptor-mediated events; 70 mg/ml for U46619-induced platelet aggregation, 64 mg/ml for U46619-induced phosphoinositide hydrolysis, and 75 mg/ml for [ On the other hand, the 100% ethanol extract only weakly inhibited aggregation induced by thrombin, ADP, or 5-HT. TXA 2 is released as a positive feedback mediator when platelets are activated by physiological agonists such as thrombin, ADP, and 5-HT. 18, 19) It has been shown that a TXA 2 receptor antagonist partially inhibits platelet aggregation induced by thrombin or ADP. 20, 21) Therefore it is assumed that the 100% ethanol extract can inhibit platelet aggregation partially induced by other stimulants except a TXA 2 receptor agonist.
HPLC analysis revealed that the 100% ethanol extract contained 15.9% piperine, 2.2% piperlongumine, and 0.9% TMPPA. When we used 200 mg/ml of the 100% ethanol extract, the concentration of piperine was 32 mg/ml (110 mM), piperlongumine was 4.4 mg/ml (14 mM), and TMPPA was 1.8 mg/ml (7.5 mM). To determinate the active substance(s), we examined the effect of piperine (110 mM), piperlongumine (14 mM), or TMPPA (7.5 mM) on U46619-induced platelet aggregation, but none of these substances inhibited U46619-induced platelet aggregation (Iwashita and Nakahata, unpublished observation). These results suggest that Piper longum L. extracts contain active constituent(s) other than piperine, piperlongumine, and TMPPA.
TXA 2 is active in various conditions and diseases such as thrombogenesis, hypertension, bronchial asthma, and poor peripheral blood circulation mediated via its pharmacological actions of platelet aggregation and contraction of smooth muscle cells. 22) The COX inhibitors aspirin and indomethacin, TXA 2 synthesis inhibitor ozagrel, and TXA 2 receptor antagonist seratrodast have been used for the treatment of these diseases. 13, 14, 23) In the present study, we showed for the first time that the extract from Piper longum L. had an inhibitory effect on platelet aggregation as a TXA 2 receptor antagonist. These
